Production (Stage)
Tharimmune, Inc.
THAR
$1.36
-$0.0124-0.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.95M | 1.76M | 1.58M | 1.37M | 1.32M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.55M | 3.85M | 3.87M | 2.37M | 2.35M |
| Operating Income | -2.55M | -3.85M | -3.87M | -2.37M | -2.35M |
| Income Before Tax | -2.54M | -3.82M | -3.80M | -2.33M | -2.26M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.54M | -3.82M | -3.80M | -2.33M | -2.26M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.54M | -3.82M | -3.80M | -2.33M | -2.26M |
| EBIT | -2.55M | -3.85M | -3.87M | -2.37M | -2.35M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.99 | -2.14 | -2.45 | -2.42 | -2.55 |
| Normalized Basic EPS | -0.62 | -1.34 | -1.53 | -1.51 | -1.59 |
| EPS Diluted | -0.99 | -2.14 | -2.45 | -2.42 | -2.55 |
| Normalized Diluted EPS | -0.62 | -1.34 | -1.53 | -1.51 | -1.59 |
| Average Basic Shares Outstanding | 2.57M | 1.79M | 1.55M | 962.10K | 885.70K |
| Average Diluted Shares Outstanding | 2.57M | 1.79M | 1.55M | 962.10K | 885.70K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |